exploring cabozantinib with nivolumab and ipilimumab in urothelial carcinoma
Published 6 years ago • 180 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
2:09
dr. apolo on cabozantinib plus nivolumab and ipilimumab in urothelial carcinoma
-
3:31
cabozantinib–nivolumab and ipilimumab combinations show potential for gu cancers | andrea apolo
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:06
dr. toni choueiri on nivolumab and cabozantinib becoming first-line therapies in rcc
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma
-
1:13
dr. apolo on the safety of nivolumab plus cabozantinib in urothelial carcinoma
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
6:30
the rationale for using cabozantinib
-
3:26
nivolumab and cabozantinib versus standard of care in renal cell carcinoma
-
1:02
results of a study examining nivolumab in metastatic bladder cancer
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
7:08
final analysis of the atlantis cabozantinib comparison
-
0:56
dr. apolo on immunotherapy combinations with cabozantinib in genitourinary tumors
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
1:43
understanding variant histologies in urothelial carcinoma: io and cabozantinib's potential
-
2:00
exploring the combination of epacadostat and pembrolizumab in urothelial carcinoma
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer